Global Biopharmaceutical Innovator Extends Pharma Specific Customer
Relationship Management (CRM) Solution
Cegedim Dendrite announced today that Bristol-Myers Squibb (NYSE:BMY)
has renewed its existing CRM and services contract and will be
implementing Mobile Intelligence™, Cegedim Dendrite’s flagship CRM
solution, to their Neurosciences sales team. The new agreement also
includes the continuance of data and technical support on their current
CRM tool. Cegedim Dendrite is the leading provider of Customer
Relationship Management (CRM) solutions that increase the efficiency and
effectiveness of sales forces in the pharmaceutical industry.
Bristol-Myers Squibb has been a Cegedim Dendrite customer since 1994. “We
are committed to helping Bristol-Myers Squibb achieve their growth goals,”
stated Laurent Schockmel, Cegedim Americas Chief Operating Officer. “Our
solutions and services are pharmaceutical by design and not a byproduct
of part-time focus or adaptations of horizontal sales force automation
tools. This enables Cegedim Dendrite to provide solutions that fit and
reflect the actual workflow of pharmaceutical managers, thereby yielding
productivity improvements while minimizing administrative tasks.”
Mobile Intelligence has been designed to improve the workflow of all
types of customer facing work forces within pharmaceutical and biotech
companies. It uses human-centered design principles and provides a
single view of the customer, empowering collaboration, fostering
communication and enhancing visibility across disciplines. Coupled with
Cegedim Dendrite’s Support Services, it is a powerful solution. Cegedim
Dendrite recently received the prestigious HDI® Support Center
Certification, the only company in its category to receive recognition
for outstanding customer service.
About Cegedim Dendrite:
Cegedim Dendrite provides the pharmaceutical companies around the world
with vital support for successful Customer Relationship Management (CRM)
activities. With nearly 200,000 sales representatives using its products
worldwide, Cegedim Dendrite is the world’s leading CRM provider for the
life sciences industry. This business unit, created in May 2007 when the
France-based Cegedim S.A. Group acquired Dendrite International, also
provides sales, marketing and regulatory compliance solutions in more
than 80 countries.
To learn more, please see our website: www.cegedimdendrite.com
About Cegedim:
Founded in 1969, Cegedim is a global technology and services company
specializing in the healthcare field. Cegedim supplies services,
technological tools, specialized software, data flow management services
and databases. Its offerings are targeted notably at healthcare
industries, pharmaceutical companies, healthcare professionals and
insurance companies.
The world leader in pharmaceutical CRM, Cegedim is also one of the
leading suppliers of strategic healthcare industry data. Cegedim employs
more than 8,400 people in 80 countries and generated revenue of €849
million in 2008. To learn more, please visit our website: www.cegedim.fr
Listed on NYSE Euronext Paris, compartment B – ISIN FR0000053506 –
Reuters CGDM.PA – Bloomberg CGM
Cegedim Dendrite
Drew Bustos, +1 908-443-2451
Global
Communications
drew.bustos@cegedimdendrite.com
or
Cegedim
Group
Aude Balleydier, +33 (0)1 49 09 68 81
Media Relations
aude.balleydier@cegedim.fr
